TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Sanofi-Aventis Norge AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
741,575
|
729,437
|
753,286 |
Financial expenses |
1,287
|
1,384
|
1,039 |
Earnings before taxes |
41,459
|
62,957
|
29,824 |
Total assets |
347,336
|
421,617
|
334,490 |
Current assets |
344,814
|
418,922
|
331,319 |
Current liabilities |
342,130
|
367,758
|
176,296 |
Equity capital |
5,205
|
53,859
|
158,194 |
- share capital |
1,797
|
1,924
|
1,866 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.5%
|
12.8%
|
47.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.6%
|
8.6%
|
4.0% |
Return on assets (ROA) |
12.3%
|
15.3%
|
9.2% |
Current ratio |
100.8%
|
113.9%
|
187.9% |
Return on equity (ROE) |
796.5%
|
116.9%
|
18.9% |
Change turnover |
60,467
|
-47,189
|
41,384 |
Change turnover % |
9%
|
-6%
|
6% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.